chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Significant increase in R facial weakness, asymmetrical facial expressions, new onset twitching (throughout all of right side of face, in areas which never had any weakness or twitching previously). Inability to close right eye fully. Sensation of numbness/tingling throughout right side of face, constant twitching under right eye, weakness with attempts at smiling  (right side of face). I had mild facial asymmetry growing up, but after the Covid vaccine, it has gotten so severe and limiting, at times I don?t want to be around people. It?s embarrassing. My eye is always dry, I have to try to force it to close more to make it look closer to how my left eye looks, and then all my right side facial muscles start twitching so much more because they are so weak. It?s awful and it seems to be getting continually worse as time goes on. It?s frustrating to have the CDC report it?s likely not a cause of Bell?s palsy to facial weakness, when I have had a stable course of only mild symptoms throughout my life for 31 years, and then immediately after receiving the vaccine, they got significantly (quality for life altering) worse. There is not just a correlation, there IS causation. Please feel free to contact me regarding more information. I want my case to be documented accurately.
Injection site pain; Tiredness; Headache; Weakness; Chills; Muscle pain; Joint pain; Fever; Feeling unwell; Diarrhea; Arm pain; This is a spontaneous report from a contactable consumer or other non hcp (patient).  A 55-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in right arm on 05May2021 at 14:55 (at the age of 55 years old) (Batch/Lot Number: EW0167) as DOSE 1, SINGLE for covid-19 immunisation. Medical history was none. The patient's concomitant medications were not reported. On 06May2021 at 10:30, the patient went home sick and had been in bed ever since. The patient had 13 of the 17 reported side effects that were on the list from (withheld). All of these symptoms started on 06May2021 but the patient was unsure what time, she just knew that she was at work and by 10:30 am she had to go home. On 06May2021, patient experienced injection site pain, tiredness, headache, weakness, chills, muscle pain, joint pain, fever, feeling unwell, diarrhea and arm pain. The tiredness may be from not eating or drinking. The patient had been taking ibuprofen for her headache and it had helped, she had one now, it just started 20-30 minutes ago, but her headache was nowhere like it was the previous day. The weakness had improved, the patient had gotten up and walked around couple of times and then sat back down. Chills: The patient had two coats on and was still freezing. The patient knew something was wrong because it was 70 degrees outside and she put on sweatpants and a sweatshirt and laid under the covers all day long. She had heat on (right now) in her room but she was not getting the chills as often or as bad. She could not really do anything about the muscle pain. She did not know if it was muscle pain but her legs were weak and she couldn't stand up at work anymore when she left work the previous day. The joint pain was the same thing as muscle pain, in her opinion. She did not know the actual temperature of her fever or if she actually had one. The patient knew she had a fever because woke up soaking wet. The patient still felt blah-ish a little bit, but not like the previous day. The arm pain was nowhere like it was the previous day. She had diarrhea but that had improved. Therapeutic measures were taken as a result of headache (headache). The outcome of tiredness was not recovered, all the other events were recovering.  No follow-up attempts are needed. No further information is expected.
Bacterial pneumonia. Treated with IV antibiotics, azithromycin and cephalexin.   Quite ill for a week (high fever, body aches, no appetite, etc.).  Well, after treatment.
Vacc given 4.5.07 on 4.12.07 Mom reported fever 102 with shaking - mild lethargy, runny nose, little cough - assumed secondary viral URI. On 4.16.07 Mom calls with large red area on left thigh and from yesterday are raised like small blister (bumps with red spot) temp 102 F, loose stools, decreased appetite red area not tender.
Aches; Nausea; Chills; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Aches), NAUSEA (Nausea), CHILLS (Chills) and HEADACHE (Headaches) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 02-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Aches), NAUSEA (Nausea), CHILLS (Chills) and HEADACHE (Headaches). At the time of the report, MYALGIA (Aches), NAUSEA (Nausea), CHILLS (Chills) and HEADACHE (Headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication reported included allergy medicine. No treatment information was provided.  The patient reported that following vaccination, the patient began to experience nauseas, aches, chills, and headaches.
Diarrhea; he is having some serious gastric issue; Sick; he is unable to talk; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 30Nov2022 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series completed, Manufacturer Unkown), for Covid-19 immunization. The following information was reported: DIARRHOEA (non-serious), outcome "unknown", described as "Diarrhea"; GASTRIC DISORDER (non-serious), outcome "unknown", described as "he is having some serious gastric issue"; ILLNESS (non-serious), outcome "unknown", described as "Sick"; MUTISM (non-serious), outcome "unknown", described as "he is unable to talk".  Additional information: Reporter stated "my husband and both received the third covid booster(Clarified as COVID-19 booster shot) this past Monday 30Nov. My husband is now traveling. He is on the plane and he is unable to talk. As of Friday, he had, we don't know if this connected with the booster, it could be a side effect, some serious diarrhea and thankfully not actually travelling but now he was at the airport and he was texting me, he is unable to talk, but he is having some serious gastric issue". Reporter wanted to know if it could be a side effect of the booster or should they think of other reason.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
blurry vision; expired dose administered; This spontaneous case was reported by a patient and describes the occurrence of VISION BLURRED (blurry vision) and EXPIRED PRODUCT ADMINISTERED (expired dose administered) in a male patient of an unknown age who received mRNA-1273 (Spikevax) (batch no. 051F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 20-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired dose administered). On 24-Apr-2022, the patient experienced VISION BLURRED (blurry vision). At the time of the report, VISION BLURRED (blurry vision) and EXPIRED PRODUCT ADMINISTERED (expired dose administered) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
Post Menactra, complain of feeling faint, weakness in arms and legs, neck pain and inability to walk or move arms-transported by ambulance  after observation in office.  Admitted for care.  Discharged to home with no complaint, doing fine at home. 11/2/06-records received from Dr's office for DOS 10/23/06 Immediate reaction with 10 minutes of receiving Menactra. C/O nausea, dizziness and became clammy. BP 83/57. Continue to C/O being weak all over. Pulse 74 patient hyperventilating and very upset. 5 minutes later BP 96/68 pale 80 no longer hyperventilating but not C/O arms and legs hurting. Unable to move self. C/O legs and arms weak, no difficulty breathing. 15 minutes later neck pain, BP 106/60 pulse 77 respirations 22. Called 911 patient taken to ER. Seen in ER: exam alert, extremity pain, pain in neck, arm and legs. HX of ADD RX with MS IV 2mg. DX: Pain, vaccine reaction.
I developed a lump under my chin which I brought to the attention of my PCP.  She wanted me to have a core CT scan and a core biopsy. After that was completed, my PCP was relieved because she said that it looked benign. I had to go see an ENT for a consult with Dr. After looking at the results of the CT scan and the biopsy he told me that it was lymph node. It's not a salivary gland. It will not go away because there is too much dead tissue there. What he is going to do, on 06/18/21, is have a surgery and remove the entire lymph node and send it off to pathology. It's not painful, but it feels very unattractive.
Patient felt dizzy after 5 minutes of sitting in wheelchair with her legs elevated (she said she had a history of fainting at the sight of needles. Took her vitals and B/P was 82/42, removed her mask to focus on breathing. O2 sats were 97% on RA, HR was 53. Ice pack placed to her neck and O2 per N/C placed at 3 L. At 10:47 she briefly lost consciousness for a few seconds and ammonia whiffs were given. Stat team called and she was taken to clinic treatment area for further observation. Patient's mother reported that patient had taken Ativan PO at 0945, same day.
I developed a raised red rash, warm to the touch, itchy area on my right arm in the vicinity of where the shot was given.  It was small, roundish and approximately 2" across.
Pediatric (5-11) age children given Pfizer 12 and up dose at Vaccine Clinic.  RN Site lead- contacted Dr. to notify and discuss next steps. Informed by Dr. there is no new symptoms are concerns to worry about at this time but to call and notify the parents of the adverse event.  RN Site lead notified the parents of the adverse event.
Patient with 2 COVID vaccines, last one 05/05/21, who admitted to hospital for surgical intervention on infected foot who incidentally tested detected for COVID during admission testing.  No respiratory concerns with COVID during his stay.  Discharged home after surgical intervention.
Information has been received from a health professional concerning a white child pt who on 17Mar97 was vaccinated with a dose of varicella virus vaccine live. Subsequently, the pt developed breakthrough varicella. The pt's breakthrough varicella was not lab confirmed. Unspecified medical attention was not sought. There was not product quality complaint involved. Additional information is not expected.
almost immediate crushing pain in forearm, hand went numb and fingers tingling. sensation of back into neck and head. black out feeling.. headache left temple. flashing orange in eyes.  lasted for up to 90 minutes.
maculopapular rash on buttock & upper thigh, lower back & trunk;macular 4mm in diameter;appears to have devel in 2-3 episodes-pruritus;
61 days prior had 1st dose of the Shingles vaccine. Had a bit of soreness at injection site but nothing that was limiting. Ten years ago received ZOSTAVAX vaccine. Patient had Herpes in eye 20 years ago; not sure which eye it was. During vaccination the administration hurt more than 1st dose. Next morning felt shivers and chillsdid not feel well. Patient not sure if was running a fever. Saturday morning had discharge in right eye, it was sore, irritated, and lots of discharge. Patient thought she was getting conjunctivitis from a friend. On Sunday went to Urgent Care, NP prescribed erythromycin and did not run a stain test. The medicine did not help. Patient went to ophthalmologist on 7/17, ran test and confirmed it was shingles. Doctor prescribed valacyclovir, swelling is down, still light sensitive and closing eye more often. Patient is going for follow-up with eye specialist on 7/19. Initial soreness on arm went away pretty quick.
Tactile. Fever and erythematous, blotchy rush all over - day after PENTACEL  and ROTARIX
Systemic: Confusion-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: slurred speech-Mild, Systemic: Weakness-Mild
April 1, 2021 I received J&J Vaccine. Nov 1, 2021 I received the Moderna Booster. Days after the booster I now have constant ringing in my ears. I also get headaches regularly most of my adult life. After the Moderna Booster I have had 2 insanely painful migraines that made me dysfunctional for an entire day with vomiting. Never experienced a migraine this intense prior to the Moderna booster.
ALREADY RECEIVED COVID-19 MODERNA VACCINES 1/29/2021  (LOT# ER8733) AND 2/26/2021 (LOT# 014M20A) STARTED NEW SERIES WITH PFIZER ON 4/7/2021. COMPLETE WITH SECOND DOSE PFIZER 4/30/2021 (LOT #ER8736)
Patient observed right arm red when waking up on 12/29/16; by the evening the area grew in size of red and swelling; today (12/30/16) at time of visit arm is warm to touch, red, raised and has spread from shoulder area down to elbow (right side only). Treated with Clindamycin 300 mg PO TID for 7-10 day and BENADRYL.
Fever, and muscle aches, weakness, arthritis was terrible. Hurt worse after shot for a couple of days
PATIENT COMPLAINED ABOUT THE REDNESS AND ITCHINESS AROUND INJECTION AREA- HEADACHE, MUSCLE PAIN AND FEVER
This spontaneous report as received from an office medical assistant via company representative referring a currently 40 year old female patient, who on an unknown date, was vaccinated with PNEUMOVAX23 (dose, route of administration and lot # not reported). Concomitant medications were not reported. Office medical assistant informed the company representative that on an unknown date, the patient started itching and her throat started to close with PNEUMOVAX23. Time later, the patient had a similar type of response with M-M-R II (Lot # 672759/0234AE), which is referred in the MARRS case # 1303USA001795. The patient's outcome was unknown. Additional information has been requested.
received a third dose of Shingrix on April 7th, 2021; This case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a 62-year-old female patient who received Herpes zoster (Shingrix) (batch number T7GA9, expiry date 11th November 2022) for prophylaxis.   On 7th April 2021, the patient received the 3rd dose of Shingrix. On 7th April 2021, unknown after receiving Shingrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.  Additional case details were reported as follows: On 7th April 2021, the patient received the 3rd dose of Shingrix, which led to extra dose administered. The healthcare professional did not reported side effects. The reporter consented to follow up.
chest congestion; hoarse cough; hoarse voice; This spontaneous case was reported by a nurse and describes the occurrence of NASAL CONGESTION (chest congestion), COUGH (hoarse cough) and DYSPHONIA (hoarse voice) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NASAL CONGESTION (chest congestion), COUGH (hoarse cough) and DYSPHONIA (hoarse voice). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, NASAL CONGESTION (chest congestion), COUGH (hoarse cough) and DYSPHONIA (hoarse voice) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No medical history reported. patient was not on regular medications. patient vaccinated with second dose on 03Aug2021.
Patient called staff over and told him she was going to faint. staff got senior nurse to help assess. Other nurse which was at pt site. Patient leaning forward and then sat back head tilted backwards, eyes opened and non-responsive. Sternal rub performed and other noxious stimuli performed. Continued until pt became responsive. app less than a minute late patient became responsive. Alert and Oriented X 4, Vital signs obtained. encouraged Patient to drink water and take deep breaths. Patient stated incident of fainting occurred prior in dermatologist office. No follow-up care was given after the doctors visit. patient became nauseas and vomited. She was clamy and pale. Patient was encouraged to go to the hospital and would not let us call EMS. Said she would not take public trasportation home. She will take a cab and call her PCP  in the morning and follow-up care. Staff verbalized that it was unsafe for her to go home rather than the hospital. patient denied any further dizziness, nausea or respiratory distress. Stated she  just felt unwell and needed to rest . Staff made her sign "Refusal of Immediate Care Against Medical Advice". Patient then called uber and staffed member escorted pt into cab at 7.12pm. We attempted to call patient multiple times between 7.23 pm - 7.30 pm.
elevation of liver enzymes; This is a spontaneous report from a contactable physician. A 71-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on 08Jan2021 (at the age of 71years) as single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. On an 19Jan2021, the patient experienced elevation of liver enzymes in the absence of other contributing factors which then normalized on further check on 22Feb2021. The outcome of event was recovered on an unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Developed recurrent nosebleeds 5 days after first dose of Pfizer vaccine.  No other bleeding issues noted.  Had a total of 7 in two weeks.  CBC and PT/PTT within normal limits.
MMRV given 1/31/07 seen 2/9/07 rash probably from measles fine rash. Seen again 2/12/07 rash now confluent. Probably from measles.
redness; swollen-ness; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE SWELLING (swollen-ness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE SWELLING (swollen-ness). At the time of the report, VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE SWELLING (swollen-ness) outcome was unknown. Not Provided          No relevant concomitant medications were reported. No treatment  information was provided Action taken with mRNA-1273 in response to the event was not applicable.
Swelling, soreness and bruising around injection site. Swelling lasted for 2-3 days, then subsided.
Within 10 minutes, brain felt a little buzzy/foggy/fuzzy. That lasted 5-10 minutes General feeling of very light tingling for 2 hours post vaccine 4 hours after vaccine, left deltoid (of vaccinated arm) began to hurt. With any contraction of the muscle, lots of soreness. Very tender to the touch. Cannot lift arm without pain.  12 hours after vaccine, left supraclavicular lymph node very sore and tender to touch 30 hours after vaccine, left supraclavicular lymph node very sore and tender to touch, and swollen
Patient arrived to the ED on 01/02/2022 with the following symptoms:  upper abdominal pain, diarrhea, and nausea  No Fever, shortness of breath, no chest pain
Site: Itching at Injection Site-Mild, Systemic: Chills-Mild, Systemic: Seizure-Medium, Systemic: Shakiness-Mild
Patient had an allergic reaction to vaccine approximately 20-30 minutes from administration. Pt c/o itchy tongue, throat, lips and had visible swelling to eyelids. Denied difficulty breathing.  Administered 50 mg/ml of Dipenhydramine IM and followed up with patient at 12:20 pm, she denied trouble breathing, stated she was no longer itching and only felt her tongue slightly heavy. C/o fatigue from the dipenhydramine.
G47.33 OBSTRUCTIVE SLEEP APNEA 7/7/2021 HYPERVOLEMIA J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 7/10/2021 HYPERVOLEMIA J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 5/30/2021 HYPERVOLEMIA R09.02 HYPOXIA 6/19/2021 HYPERVOLEMIA G47.33 OBSTRUCTIVE SLEEP APNEA 7/7/2021 DIASTOLIC HEART FAILURE, UNSPECIFIED ACUITY J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 7/10/2021 DIASTOLIC HEART FAILURE, UNSPECIFIED ACUITY J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 5/30/2021 DIASTOLIC HEART FAILURE, UNSPECIFIED ACUITY R09.02 HYPOXIA 6/19/2021 DIASTOLIC HEART FAILURE, UNSPECIFIED ACUITY G47.33 OBSTRUCTIVE SLEEP APNEA 7/7/2021 ATHEROSCLEROSIS OF AORTA J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 7/10/2021 ATHEROSCLEROSIS OF AORTA J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 5/30/2021 ATHEROSCLEROSIS OF AORTA R09.02 HYPOXIA 6/19/2021 ATHEROSCLEROSIS OF AORTA
mom reports pt began throwing up milk when fed 2hr p/vax cont to do so AM of 22JAN98;mom instructed to take child to see MD;
Swelling at the injection site; Redness at the injection site; Rash in the upper arm; Slight headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE RASH (Rash in the upper arm) and HEADACHE (Slight headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. Unknown and Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 17-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Apr-2021, the patient experienced VACCINATION SITE SWELLING (Swelling at the injection site). 17-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE RASH (Rash in the upper arm) and HEADACHE (Slight headache). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, VACCINATION SITE SWELLING (Swelling at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE RASH (Rash in the upper arm) and HEADACHE (Slight headache) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  Concomitant medication not provided.  Treatment included wet/cold rags on the inflammation area.